Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Depreciation Expense (2017 - 2025)

Selectis Health's Depreciation Expense history spans 11 years, with the latest figure at $364699.0 for Q3 2025.

  • For Q3 2025, Depreciation Expense fell 2.52% year-over-year to $364699.0; the TTM value through Sep 2025 reached $1.5 million, down 10.59%, while the annual FY2023 figure was $1.7 million, 7.06% down from the prior year.
  • Depreciation Expense for Q3 2025 was $364699.0 at Selectis Health, up from $362742.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $1.7 million in Q1 2021 and bottomed at -$447070.0 in Q3 2021.
  • The 5-year median for Depreciation Expense is $430754.0 (2023), against an average of $440593.9.
  • The largest YoY upside for Depreciation Expense was 366.0% in 2021 against a maximum downside of 215.29% in 2021.
  • A 5-year view of Depreciation Expense shows it stood at $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then decreased by 13.15% to $374118.0 in 2024, then dropped by 2.52% to $364699.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Depreciation Expense are $364699.0 (Q3 2025), $362742.0 (Q2 2025), and $363020.0 (Q1 2025).